Palisade Bio (PALI) Receivables - Other (2016 - 2023)
Palisade Bio's (PALI) quarterly Receivables - Other came in at $105625.0 in Q4 2023, down 25.22% year-on-year from $141250.0 in Q4 2022, and little changed on a QoQ basis from $105625.0 in Q3 2023.
Palisade Bio (PALI) Receivables - Other (2016 - 2023) Analysis & Trends
Palisade Bio (PALI) has 7 years of Receivables - Other data on file, last reported at $105625.0 in Q4 2023.
- On a quarterly basis, Receivables - Other fell 25.22% year-over-year to $105625.0 in Q4 2023; TTM through Dec 2023 was $105625.0, a 25.22% decrease from a year earlier, with the FY2023 full-year figure at $105625.0, down 25.22% from the prior year.
- Receivables - Other for Q4 2023 stood at $105625.0, roughly flat from $105625.0 in the prior quarter.
- Over the last five years, Receivables - Other for PALI reached as high as $229000.0 in Q1 2019 and fell as low as $105625.0 in Q2 2023.
- Historically, Receivables - Other has averaged $187375.0 across 4 years, with a median of $229000.0 in 2019.
- Across the five-year window, Receivables - Other surged 267.88% in 2019 and retreated 25.22% in 2023, its largest moves.
- Year by year, Receivables - Other stood at $229000.0 in 2019, then changed by 0.0% to $229000.0 in 2020, then slumped by 38.32% to $141250.0 in 2022, then declined by 25.22% to $105625.0 in 2023.
- Per Business Quant data, the three most recent Receivables - Other figures were $105625.0 in Q4 2023, $105625.0 in Q3 2023, and $105625.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Palisade Bio | 985.76 | -132.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 105,625.00 |
| Dec 31, 2023 | 105,625.00 |
| Sep 30, 2023 | 105,625.00 |
| Sep 30, 2023 | 105,625.00 |
| Jun 30, 2023 | 105,625.00 |
| Jun 30, 2023 | 105,625.00 |
| Dec 31, 2022 | 141,250.00 |
| Dec 31, 2022 | 141,250.00 |
| Dec 31, 2020 | 229,000.00 |
| Dec 31, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Sep 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Jun 30, 2020 | 229,000.00 |
| Mar 31, 2020 | 229,000.00 |
| Mar 31, 2020 | 229,000.00 |
| Sep 30, 2019 | 229,000.00 |
| Sep 30, 2019 | 229,000.00 |
| Jun 30, 2019 | 229,000.00 |
| Jun 30, 2019 | 229,000.00 |